Jean-Alexis Grimaud,
Research Director,
President of Matriscience
Research Director,
President of Matriscience
Professor Jean-Alexis Grimaud (Université Paris VI) is an M.D., an anatomic pathologist and the former director of the CNRS URA 1459 research unit at the Institut Pasteur.
From 1977 to 1996, his research focused on the exploration of tissue fibrosis, particularly hepatic fibrosis. Starting from 1985, the discovery of the anti-fibrotic effect of gamma interferon in hepatitis C was followed by the introduction of the notion of matrix receptors to cytokines (Patent ASCIII dipalmitoyl hydroxyproline, Merck KGaA Darmstadt license) (Neurodermine Patent Matriscience License). Professor Grimaud is the author and co-author of 214 PubMed-indexed scientific publications, including the article entitled “Medical Dermocosmetology: How to invest in reliable claims” which illustrates the orientation he has taken since 2010 as the Research Director of Matriscience (Eur J Dermatol. 2010 Jul-Aug; 20(4):423).
From 1977 to 1996, his research focused on the exploration of tissue fibrosis, particularly hepatic fibrosis. Starting from 1985, the discovery of the anti-fibrotic effect of gamma interferon in hepatitis C was followed by the introduction of the notion of matrix receptors to cytokines (Patent ASCIII dipalmitoyl hydroxyproline, Merck KGaA Darmstadt license) (Neurodermine Patent Matriscience License). Professor Grimaud is the author and co-author of 214 PubMed-indexed scientific publications, including the article entitled “Medical Dermocosmetology: How to invest in reliable claims” which illustrates the orientation he has taken since 2010 as the Research Director of Matriscience (Eur J Dermatol. 2010 Jul-Aug; 20(4):423).